CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday

CollPlant Biotechnologies (NASDAQ:CLGN) is expected to be announcing its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.42) per share and revenue of $0.36 million for the quarter.

CollPlant Biotechnologies Stock Up 0.8 %

Shares of CLGN traded up $0.03 during mid-day trading on Thursday, hitting $3.12. 602 shares of the company traded hands, compared to its average volume of 10,018. The company has a market capitalization of $35.68 million, a PE ratio of -2.02 and a beta of 1.07. The business has a 50 day moving average of $3.61 and a 200 day moving average of $4.04. CollPlant Biotechnologies has a 1-year low of $3.00 and a 1-year high of $6.75.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CLGN. D. Boral Capital reaffirmed a “buy” rating and issued a $14.00 price target on shares of CollPlant Biotechnologies in a report on Wednesday, February 12th. HC Wainwright restated a “buy” rating and issued a $11.00 target price on shares of CollPlant Biotechnologies in a research note on Friday, November 29th.

About CollPlant Biotechnologies

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.